Sign inJoin waitlistJoin the waitlist

Manmeet Ahluwalia

Rotation Director, Elective in Neuro-Oncology · Florida International University

Credentials: · · · · · · ·

History

solid tumor Division · Baptist Health Herbert Wertheim Cancer Institute
Present
neuro oncology Division · Baptist Health Herbert Wertheim Cancer Institute
Present
medical oncology Division · Baptist Health Herbert Wertheim Cancer Institute
Present

Roswell Park Cancer Institute
2009–2011
Roswell Park Cancer Institute
2006–2009
Fairview Hospital-GME
Case Western - Weatherhead School of Management
Maulana Azad Medical College

Research

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
JAMA · 2017 · 2,133 citations
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial
JAMA Oncology · 2020 · 1,259 citations
Brain metastases
Review · Nature Reviews Disease Primers · 2019 · 877 citations

RK
Rupesh Kotecha
58 papers · 14 as a resident
Samuel Chao
51 papers
David Peereboom
50 papers
MV
Michael Vogelbaum
46 papers
Gene Barnett
45 papers
John Suh
44 papers
Minesh Mehta
39 papers
Erin Murphy
35 papers · 4 as a fellow
PW
Patrick Wen
35 papers
Alireza Mohammadi
32 papers
Lilyana Angelov
29 papers
Glen Stevens
24 papers

Grants

Radiomic Spatial Maps for Identifying Viable Tumor Extent on Multi-Parametric MRI for Glioblastoma
National Cancer Institute · R01
PI · $3M · University of Wisconsin-Madison
2024–2029
Quantitative Imaging Phenotypic Classifier for Distinguishing Radiation Effects from Tumor Recurrence in Glioblastoma
National Cancer Institute · R01
PI · $2.9M · University of Wisconsin-Madison
2022–2028

Clinical trials

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
Principal investigator · Not yet recruiting · Phase 1
Baptist Health South Florida
2026–2029
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer
Principal investigator · Terminated · Phase 1
Baptist Health South Florida
2024–2025
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Principal investigator · Recruiting · Phase 3
InSightec
2022–2027
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Principal investigator · Completed · Phase 3
NovoCure GmbH
2016–2024

Honors

Fellowship of the American Society of Clinical Oncology (ASCO) (FASCO)
American Society of Clinical Oncology

baptisthealth.net